MoneyWorks4Me

Ajanta Pharma informs about certificate

08 Jul 2025 Evaluate

Ajanta Pharma has informed that it enclosed certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June 2025 received from MUFG Intime India, Registrar and Share Transfer Agent of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1861.75
Dr. Reddys Labs. 1172.60
Cipla 1379.35
Lupin 2079.45
Zydus Lifesciences 1137.05
View more..